2016
DOI: 10.1007/s00113-015-0136-2
|View full text |Cite
|
Sign up to set email alerts
|

Arthroskopische Behandlung von Knorpelverletzungen am Sprunggelenk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…www.advancedsciencenews.com www.biotechnology-journal.com the patient, thus, chondrocytes may have to be harvested from the uninjured ipsilateral knee and the problems of cultureexpanding the cells after harvest, namely cell senescence, [10] dedifferentiation, [11] and cost, preclude universal adoption across health organizations. [12] Due to the limitations associated with the use of chondrocytes, stem cells have emerged as a viable alternative for cartilage regenerative medicine strategies. The strategies involved in cartilage regeneration can be thought of as a triad.…”
Section: Richardmentioning
confidence: 99%
See 1 more Smart Citation
“…www.advancedsciencenews.com www.biotechnology-journal.com the patient, thus, chondrocytes may have to be harvested from the uninjured ipsilateral knee and the problems of cultureexpanding the cells after harvest, namely cell senescence, [10] dedifferentiation, [11] and cost, preclude universal adoption across health organizations. [12] Due to the limitations associated with the use of chondrocytes, stem cells have emerged as a viable alternative for cartilage regenerative medicine strategies. The strategies involved in cartilage regeneration can be thought of as a triad.…”
Section: Richardmentioning
confidence: 99%
“…The technique has been shown to have favorable long‐term results when treating cartilage lesions in the ankle but a meta‐analysis in 2012 found insufficient evidence to support ACI over the simple and inexpensive technique of bone marrow stimulation . Furthermore, the two‐step procedure of ACI doubles the surgical risk to the patient, thus, chondrocytes may have to be harvested from the uninjured ipsilateral knee and the problems of culture‐expanding the cells after harvest, namely cell senescence, dedifferentiation, and cost, preclude universal adoption across health organizations . Due to the limitations associated with the use of chondrocytes, stem cells have emerged as a viable alternative for cartilage regenerative medicine strategies.…”
Section: Introductionmentioning
confidence: 99%